• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳球菌表面展示轮状病毒 VP6 蛋白的抗原性和免疫原性。

Antigenicity and immunogenicity of rotavirus VP6 protein expressed on the surface of Lactococcus lactis.

机构信息

Laboratorio de Inmunología y Virología, Universidad Nacional de Quilmes, Bernal, B1876BXD Buenos Aires, Argentina.

出版信息

Biomed Res Int. 2013;2013:298598. doi: 10.1155/2013/298598. Epub 2013 Jul 24.

DOI:10.1155/2013/298598
PMID:23984337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3741945/
Abstract

Group A rotaviruses are the major etiologic agents of acute gastroenteritis worldwide in children and young animals. Among its structural proteins, VP6 is the most immunogenic and is highly conserved within this group. Lactococcus lactis is a food-grade, Gram-positive, and nonpathogenic lactic acid bacteria that has already been explored as a mucosal delivery system of heterologous antigens. In this work, the nisin-controlled expression system was used to display the VP6 protein at the cell surface of L. lactis. Conditions for optimal gene expression were established by testing different nisin concentrations, cell density at induction, and incubation times after induction. Cytoplasmic and cell wall protein extracts were analyzed by Western blot and surface expression was confirmed by flow cytometry. Both analysis provided evidence that VP6 was efficiently expressed and displayed on the cell surface of L. lactis. Furthermore, the humoral response of mice immunized with recombinant L. lactis was evaluated and the displayed recombinant VP6 protein proved to be immunogenic. In conclusion, this is the first report of displaying VP6 protein on the surface of L. lactis to induce a specific immune response against rotavirus. These results provide the basis for further evaluation of this VP6-displaying L. lactis as a mucosal delivery vector in a mouse model of rotavirus infection.

摘要

A 组轮状病毒是全球儿童和幼小动物急性胃肠炎的主要病原体。在其结构蛋白中,VP6 是最具免疫原性的,并且在该组内高度保守。乳球菌是一种食品级、革兰氏阳性、非致病性的乳酸菌,已经被探索作为异源抗原的黏膜传递系统。在这项工作中,使用乳链菌肽控制表达系统将 VP6 蛋白展示在乳球菌的细胞表面。通过测试不同的乳链菌肽浓度、诱导时的细胞密度和诱导后的孵育时间,确定了最佳基因表达的条件。通过 Western blot 分析细胞质和细胞壁蛋白提取物,并通过流式细胞术确认表面表达。这两种分析都提供了证据表明 VP6 被有效地表达并展示在乳球菌的细胞表面上。此外,还评估了用重组乳球菌免疫的小鼠的体液免疫反应,证明了展示的重组 VP6 蛋白具有免疫原性。总之,这是首次报道将 VP6 蛋白展示在乳球菌表面上,以诱导针对轮状病毒的特异性免疫反应。这些结果为进一步评估这种展示 VP6 的乳球菌作为轮状病毒感染小鼠模型中的黏膜传递载体提供了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0f/3741945/72f846e917ad/BMRI2013-298598.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0f/3741945/28a4f9698f4f/BMRI2013-298598.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0f/3741945/c0df92240005/BMRI2013-298598.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0f/3741945/b95944660553/BMRI2013-298598.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0f/3741945/72f846e917ad/BMRI2013-298598.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0f/3741945/28a4f9698f4f/BMRI2013-298598.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0f/3741945/c0df92240005/BMRI2013-298598.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0f/3741945/b95944660553/BMRI2013-298598.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0f/3741945/72f846e917ad/BMRI2013-298598.004.jpg

相似文献

1
Antigenicity and immunogenicity of rotavirus VP6 protein expressed on the surface of Lactococcus lactis.乳球菌表面展示轮状病毒 VP6 蛋白的抗原性和免疫原性。
Biomed Res Int. 2013;2013:298598. doi: 10.1155/2013/298598. Epub 2013 Jul 24.
2
Rotavirus VP6 protein mucosally delivered by cell wall-derived particles from Lactococcus lactis induces protection against infection in a murine model.乳球菌细胞壁来源颗粒递呈的轮状病毒 VP6 蛋白黏膜免疫诱导小鼠产生保护性免疫。
PLoS One. 2018 Sep 7;13(9):e0203700. doi: 10.1371/journal.pone.0203700. eCollection 2018.
3
Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice.乳酸乳球菌产生的轮状病毒vp7抗原可在小鼠体内诱导中和抗体。
J Appl Microbiol. 2005;99(5):1158-64. doi: 10.1111/j.1365-2672.2005.02709.x.
4
Induction of Immunogenic Response in BALB/c Mice by Live and Killed Form of Recombinant Lactococcus lactis Displaying EG95 of Echinococcus granulosus.经重组乳球菌活疫苗和死疫苗诱导 BALB/c 小鼠产生免疫应答,展示细粒棘球绦虫 EG95 抗原。
Iran Biomed J. 2021 Jul 1;25(4):284-96. doi: 10.52547/ibj.25.4.284.
5
Self-assembling Rotavirus VP6 Nanoparticle Vaccines Expressed in Escherichia coli Elicit Systemic and Mucosal Responses in Mice.在大肠杆菌中表达的自组装轮状病毒VP6纳米颗粒疫苗可引发小鼠的全身和黏膜免疫反应。
Protein Pept Lett. 2019;26(12):904-909. doi: 10.2174/0929866526666190820161328.
6
Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.轮状病毒VP6管状结构和病毒样颗粒在小鼠中的免疫原性比较
Hum Vaccin Immunother. 2013 Sep;9(9):1991-2001. doi: 10.4161/hv.25249. Epub 2013 Jun 18.
7
Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.针对轮状病毒中层蛋白VP6引发的免疫反应可在体外和体内抑制病毒复制。
Hum Vaccin Immunother. 2014;10(7):2039-47. doi: 10.4161/hv.28858.
8
Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice.口服表达轮状病毒 VP8 亚单位的活乳球菌可诱导小鼠产生特异性免疫应答。
J Virol Methods. 2011 Jul;175(1):28-37. doi: 10.1016/j.jviromet.2011.04.011. Epub 2011 Apr 20.
9
Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.将轮状病毒VP6靶向递送至DEC-205可诱导小鼠对感染产生保护作用。
Vaccine. 2015 Aug 20;33(35):4228-37. doi: 10.1016/j.vaccine.2015.03.080. Epub 2015 Apr 4.
10
Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.轮状病毒衣壳VP6管状和球形纳米结构与诺如病毒病毒样颗粒共同递送时可作为局部佐剂。
Clin Exp Immunol. 2017 Sep;189(3):331-341. doi: 10.1111/cei.12977. Epub 2017 May 16.

引用本文的文献

1
Rotavirus Infections: Pathophysiology, Symptoms, and Vaccination.轮状病毒感染:病理生理学、症状及疫苗接种
Pathogens. 2025 May 14;14(5):480. doi: 10.3390/pathogens14050480.
2
Biotechnological Interventions for the Production of Subunit Vaccines Against Group A Rotavirus.用于生产抗A组轮状病毒亚单位疫苗的生物技术干预措施。
Cell Biochem Funct. 2024 Dec;42(8):e70031. doi: 10.1002/cbf.70031.
3
Oral Immunization With a M Cell-Targeting Recombinant Vaccine LL-plSAM-FVpE Stimulate Protective Immunity Against in Mice.口服黏膜免疫用 M 细胞靶向重组疫苗 LL-plSAM-FVpE 刺激小鼠产生针对 的保护性免疫。

本文引用的文献

1
HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice.单纯疱疹病毒 1 扩增子载体启动异源轮状病毒样颗粒的产生,并在小鼠中诱导轮状病毒特异性免疫应答。
Mol Ther. 2012 Sep;20(9):1810-1820. doi: 10.1038/mt.2012.108. Epub 2012 Jun 19.
2
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines.乳球菌和乳杆菌作为黏膜传递载体的治疗性蛋白质和 DNA 疫苗。
Microb Cell Fact. 2011 Aug 30;10 Suppl 1(Suppl 1):S4. doi: 10.1186/1475-2859-10-S1-S4.
3
Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice.
Front Immunol. 2022 Jul 7;13:918160. doi: 10.3389/fimmu.2022.918160. eCollection 2022.
4
Rotavirus vaccines: progress and new developments.轮状病毒疫苗:进展与新动向。
Expert Opin Biol Ther. 2022 Mar;22(3):423-432. doi: 10.1080/14712598.2021.1977279. Epub 2021 Sep 10.
5
Established and new rotavirus vaccines: a comprehensive review for healthcare professionals.已上市和新研发的轮状病毒疫苗:面向医疗保健专业人员的综合述评。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1870395. doi: 10.1080/21645515.2020.1870395. Epub 2021 Feb 19.
6
Combined use of lactic-acid-producing bacteria as probiotics and rotavirus vaccine candidates expressing virus-specific proteins.联合使用产乳酸细菌作为益生菌和表达病毒特异性蛋白的轮状病毒候选疫苗。
Arch Virol. 2021 Apr;166(4):995-1006. doi: 10.1007/s00705-021-04964-9. Epub 2021 Feb 3.
7
Nisin M: a Bioengineered Nisin A Variant That Retains Full Induction Capacity but Has Significantly Reduced Antimicrobial Activity.乳链菌肽 M:一种生物工程变异的乳链菌肽 A,保留了完全的诱导能力,但抗菌活性显著降低。
Appl Environ Microbiol. 2020 Jul 20;86(15). doi: 10.1128/AEM.00984-20.
8
The regulatory effect of Lactobacillus rhamnosus GG on T lymphocyte and the development of intestinal villi in piglets of different periods.鼠李糖乳杆菌GG对不同时期仔猪T淋巴细胞及肠绒毛发育的调节作用。
AMB Express. 2020 Apr 17;10(1):76. doi: 10.1186/s13568-020-00980-1.
9
Immunomodulatory Properties of Bacterium-Like Particles Obtained From Immunobiotic Lactobacilli: Prospects for Their Use as Mucosal Adjuvants.免疫生物性乳杆菌来源的菌样颗粒的免疫调节特性:作为黏膜佐剂的应用前景。
Front Immunol. 2020 Jan 23;11:15. doi: 10.3389/fimmu.2020.00015. eCollection 2020.
10
Rotavirus VP6 protein mucosally delivered by cell wall-derived particles from Lactococcus lactis induces protection against infection in a murine model.乳球菌细胞壁来源颗粒递呈的轮状病毒 VP6 蛋白黏膜免疫诱导小鼠产生保护性免疫。
PLoS One. 2018 Sep 7;13(9):e0203700. doi: 10.1371/journal.pone.0203700. eCollection 2018.
口服表达轮状病毒 VP8 亚单位的活乳球菌可诱导小鼠产生特异性免疫应答。
J Virol Methods. 2011 Jul;175(1):28-37. doi: 10.1016/j.jviromet.2011.04.011. Epub 2011 Apr 20.
4
Generation and evaluation of A2-expressing Lactococcus lactis live vaccines against Leishmania donovani in BALB/c mice.用表达 A2 的乳球菌活疫苗防治 BALB/c 小鼠中的杜氏利什曼原虫。
J Med Microbiol. 2011 Sep;60(Pt 9):1248-1260. doi: 10.1099/jmm.0.029959-0. Epub 2011 Apr 28.
5
Oral immunization of mice with Lactococcus lactis expressing the rotavirus VP8* protein.用表达轮状病毒 VP8* 蛋白的乳球菌对小鼠进行口服免疫。
Biotechnol Lett. 2011 Jun;33(6):1169-75. doi: 10.1007/s10529-011-0551-6. Epub 2011 Feb 8.
6
Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production.用乳酸乳球菌表达的猪轮状病毒VP4外衣壳蛋白进行口服疫苗接种可诱导特异性抗体产生。
J Biomed Biotechnol. 2010;2010:708460. doi: 10.1155/2010/708460. Epub 2010 Jun 6.
7
Rotavirus vaccines for global use: what are the remaining issues and challenges?全球通用的轮状病毒疫苗:尚存哪些问题与挑战?
Hum Vaccin. 2010 May;6(5):425-7. doi: 10.4161/hv.6.5.11180. Epub 2010 May 12.
8
Mechanisms of protection against rotavirus infection and disease.预防轮状病毒感染和疾病的机制。
Pediatr Infect Dis J. 2009 Mar;28(3 Suppl):S57-9. doi: 10.1097/INF.0b013e3181967c16.
9
Why does the world need another rotavirus vaccine?为什么世界需要另一种轮状病毒疫苗?
Ther Clin Risk Manag. 2008 Feb;4(1):49-63. doi: 10.2147/tcrm.s821.
10
Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge.用VP6和作为佐剂的LT(R192G)或CTA1-DD对小鼠进行直肠内免疫,可在EDIM攻击后防止粪便中轮状病毒排出。
Vaccine. 2007 Aug 14;25(33):6224-31. doi: 10.1016/j.vaccine.2007.05.065. Epub 2007 Jun 21.